NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) resulting from allegations that Spectrum Pharmaceuticals may have issued materially misleading business information to the investing public. SO WHAT: If you purchased […]

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Palantir Technologies Inc. (NYSE: PLTR) between November 9, 2021 and May 6, 2022, both dates inclusive (the “Class Period”), of the important November 14, 2022 lead plaintiff deadline. SO WHAT: If […]

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of U.S. Bancorp (NYSE: USB) between August 1, 2019 and July 28, 2022, both dates inclusive (the “Class Period”). A class action […]

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of International Game Technology PLC (NYSE: IGT) between March 16, 2018 and August 29, 2022, both dates inclusive (the “Class Period”), of the important December 13, 2022 lead plaintiff deadline. SO WHAT: […]

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) resulting from allegations that Y-mAbs may have issued materially misleading business information to the investing public. SO WHAT: If you […]